RS50125B - Kalcijum kompleks etilendiaminskih derivata koji sadrže fosfor - Google Patents

Kalcijum kompleks etilendiaminskih derivata koji sadrže fosfor

Info

Publication number
RS50125B
RS50125B YUP-161/02A YUP16102A RS50125B RS 50125 B RS50125 B RS 50125B YU P16102 A YUP16102 A YU P16102A RS 50125 B RS50125 B RS 50125B
Authority
RS
Serbia
Prior art keywords
ethylendiamine
derivatives
calcium complex
phosphorus containing
capa
Prior art date
Application number
YUP-161/02A
Other languages
English (en)
Serbian (sr)
Inventor
Johannes Platzek
Ulrich Niedeballa
Gunter Michl
Original Assignee
Bayer Schering Pharma Aktiengesellschaft,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7922563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS50125(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1999144893 external-priority patent/DE19944893C2/de
Application filed by Bayer Schering Pharma Aktiengesellschaft, filed Critical Bayer Schering Pharma Aktiengesellschaft,
Publication of YU16102A publication Critical patent/YU16102A/sh
Publication of RS50125B publication Critical patent/RS50125B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/04Chelating agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
YUP-161/02A 1999-09-09 2000-09-06 Kalcijum kompleks etilendiaminskih derivata koji sadrže fosfor RS50125B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1999144893 DE19944893C2 (de) 1999-09-09 1999-09-09 Calcium-Komplex von [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-. kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6, .kappa.N9,.kappa.O11]1-oxidato(6-)]-, hexahydrogen, dessen Salze und diese Komplexe enthaltende pharmazeutische Mittel

Publications (2)

Publication Number Publication Date
YU16102A YU16102A (sh) 2005-06-10
RS50125B true RS50125B (sr) 2009-03-25

Family

ID=7922563

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-161/02A RS50125B (sr) 1999-09-09 2000-09-06 Kalcijum kompleks etilendiaminskih derivata koji sadrže fosfor

Country Status (30)

Country Link
EP (1) EP1210353B1 (zh)
JP (1) JP2003508537A (zh)
KR (1) KR100650090B1 (zh)
CN (1) CN100341883C (zh)
AT (1) ATE245159T1 (zh)
AU (1) AU783982B2 (zh)
BG (1) BG65280B1 (zh)
BR (1) BR0013871A (zh)
CA (1) CA2380766C (zh)
CZ (1) CZ2002834A3 (zh)
DE (2) DE19964224B4 (zh)
DK (1) DK1210353T3 (zh)
EE (1) EE05106B1 (zh)
ES (1) ES2202178T3 (zh)
HK (1) HK1050202A1 (zh)
HR (1) HRP20020302B1 (zh)
HU (1) HUP0202873A3 (zh)
IL (1) IL148563A (zh)
MX (1) MXPA02001583A (zh)
NO (1) NO20021167D0 (zh)
NZ (1) NZ517708A (zh)
PL (1) PL354749A1 (zh)
PT (1) PT1210353E (zh)
RS (1) RS50125B (zh)
RU (1) RU2247727C2 (zh)
SK (1) SK3242002A3 (zh)
TW (1) TWI263641B (zh)
UA (1) UA74165C2 (zh)
WO (1) WO2001018011A1 (zh)
ZA (1) ZA200202742B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201514188A (zh) * 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
CN114845990A (zh) 2019-12-20 2022-08-02 伯拉考成像股份公司 钙bopta配合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
TW319763B (zh) * 1995-02-01 1997-11-11 Epix Medical Inc
US5919967A (en) * 1997-04-11 1999-07-06 Epix Medical, Inc. Process for synthesizing phosphodiesters

Also Published As

Publication number Publication date
DE19964224B4 (de) 2005-09-01
ES2202178T3 (es) 2004-04-01
SK3242002A3 (en) 2002-10-08
JP2003508537A (ja) 2003-03-04
HK1050202A1 (en) 2003-06-13
YU16102A (sh) 2005-06-10
WO2001018011A1 (en) 2001-03-15
IL148563A (en) 2005-12-18
KR100650090B1 (ko) 2006-11-27
HUP0202873A2 (hu) 2002-12-28
EE05106B1 (et) 2008-12-15
WO2001018011A9 (en) 2002-09-06
DE60003931T2 (de) 2004-05-27
EE200200090A (et) 2003-04-15
DE60003931D1 (de) 2003-08-21
ATE245159T1 (de) 2003-08-15
DE19964224A1 (de) 2001-06-28
CN100341883C (zh) 2007-10-10
CA2380766A1 (en) 2001-03-15
IL148563A0 (en) 2002-09-12
KR20020025256A (ko) 2002-04-03
EP1210353A1 (en) 2002-06-05
HRP20020302B1 (en) 2005-08-31
NZ517708A (en) 2003-10-31
CA2380766C (en) 2008-11-25
CZ2002834A3 (cs) 2002-07-17
BR0013871A (pt) 2002-05-21
AU7774900A (en) 2001-04-10
AU783982B2 (en) 2006-01-12
NO20021167L (no) 2002-03-08
PL354749A1 (en) 2004-02-23
CN1373765A (zh) 2002-10-09
HUP0202873A3 (en) 2003-12-29
MXPA02001583A (es) 2004-04-05
BG106488A (en) 2002-10-31
BG65280B1 (bg) 2007-11-30
ZA200202742B (en) 2003-09-23
DK1210353T3 (da) 2003-10-27
HRP20020302A2 (en) 2004-02-29
NO20021167D0 (no) 2002-03-08
PT1210353E (pt) 2003-11-28
TWI263641B (en) 2006-10-11
RU2247727C2 (ru) 2005-03-10
EP1210353B1 (en) 2003-07-16
UA74165C2 (uk) 2005-11-15

Similar Documents

Publication Publication Date Title
TNSN95083A1 (fr) Heteroaryl-oxazolidinones a 5 membres
BRPI0111222B8 (pt) derivados fosfonados de glicopeptídeo.
TNSN99126A1 (fr) Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99125A1 (fr) Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97008A1 (fr) Thienyl et furanyl oxazolidinediones pyrido-condenses.
CA2349227A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
WO2002098856A3 (en) Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
AU6797298A (en) Halo-alkoxycarbonyl prodrugs
RS50125B (sr) Kalcijum kompleks etilendiaminskih derivata koji sadrže fosfor
PT80191B (en) Process for preparing substituted benzopyrans useful as medicaments
ES8606297A1 (es) Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimidazo(2,1-b) quinazolinil)-oxialquilamidas
ES2004845A4 (es) Flavonoides sinteticos como inhibidores de leucotrienos y 5-lipoxigenasa.
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
AP2001002369A0 (en) Pharmaceutical complex.
AU4708293A (en) Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs
EP0790247A4 (en) TETRAHYDROISOCHINOLINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
BR9914739A (pt) éster de ácido fosfórico
UA37211C2 (uk) Похідні 1,4-дигідропіридину у формі рацемату або енантіомерів, 2-хлор-3-ціанобензальдегід як проміжний продукт для їх одержання та фармацевтична композиція, що має антагоністичну активність по відношенню до катіонів кальцію
MX9703853A (es) Esteres de iminooxilcrotonato, su preparacion y su uso.
TNSN97042A1 (fr) Derives de quinoxaline utiles en therapeutique, procede pour leur preparation et formulations pharmaceutiques les contenant.
MY133775A (en) Tetrahydrofuran antifungal phosphate
GR1002663B (el) Παραγωγη βασης φυτοχωματων απο αγροτικα υποπροιοντα.
CA2180717A1 (en) Use of phosphorus derivatives of alkaloids for treating endocrinopathies
WO2000018732A3 (de) Disubstituierte pyrrolidinone, diese verbindungen enthaltende arzneimittel und deren verwendung sowie ihre herstellung
AU1738792A (en) Small block chevrolet v8 universal harmonic balancer timing mark check gauge